Relationship Between Amphetamine Concentrations in Saliva and Serum in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Effect of Conditions for Sampling of Human Saliva on the Results of Determination of Macro- and Micronutrients

(2020) S. S. Savinov et al.   JOURNAL OF ANALYTICAL CHEMISTRY

Effect of Chewing on the Expression of Salivary Protein Composition: A Systematic Review

(2019) Khaled Al‐Manei et al.   Proteomics Clinical Applications

A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants

(2018) Laura Hutchinson et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Relationship among perceived stress, xerostomia, and salivary flow rate in patients visiting a saliva clinic

(2018) Marjolein S. Bulthuis et al.   Clinical Oral Investigations

Serum and Saliva Concentrations of Venlafaxine, O-Desmethylvenlafaxine, Quetiapine, and Citalopram in Psychiatric Patients

(2018) Katharina Ebert et al.   THERAPEUTIC DRUG MONITORING

Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Antipsychotics

(2018) Sanne M. Kloosterboer et al.   THERAPEUTIC DRUG MONITORING

Interindividual and Intraindividual Variation of Methylphenidate Concentrations in Serum and Saliva of Patients With Attention-Deficit/Hyperactivity Disorder

(2018) Joshua Preiskorn et al.   THERAPEUTIC DRUG MONITORING

The Clinical Pharmacokinetics of Amphetamines Utilized in the Treatment of Attention-Deficit/Hyperactivity Disorder

(2017) John S. Markowitz et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

(2017) C. Hiemke et al.   PHARMACOPSYCHIATRY

Quantification of Methylphenidate, Dexamphetamine, and Atomoxetine in Human Serum and Oral Fluid by HPLC With Fluorescence Detection

(2016) Benedikt Stegmann et al.   THERAPEUTIC DRUG MONITORING

Salivary hypofunction: An update on aetiology, diagnosis and therapeutics

(2015) Jamil Saleh et al.   ARCHIVES OF ORAL BIOLOGY

Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population

(2011) Paul Hodgkins et al.   CURRENT MEDICAL RESEARCH AND OPINION

Correlation Between Methylphenidate and Ritalinic Acid Concentrations in Oral Fluid and Plasma

(2010) E. Marchei et al.   CLINICAL CHEMISTRY

Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: A single-dose, randomized, open-label, crossover study

(2010) Samuel W. Boellner et al.   CLINICAL THERAPEUTICS

Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine

(2010) Pennick   Neuropsychiatric Disease and Treatment

Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment

(2009) Elizabeth Pappadopulos et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Improving Pediatric Dosing Through Pediatric Initiatives: What We Have Learned

(2008) W. Rodriguez et al.   PEDIATRICS